FDA Approves First Blood Test to Help Diagnose Alzheimer’s Disease
The U.S. Food and Drug Administration (FDA) has approved the first blood test to assist in the diagnosis of Alzheimer’s disease. Alzheimer’s Orange County (AlzOC) recognizes this development as a notable advancement in the ongoing effort to improve diagnostic options for individuals experiencing cognitive decline. The test, from Fujirebio Diagnostics Inc., identifies blood-based biomarkers associated